Stemnovate Limited

Stemnovate Limited Mitochondrial Platform is revolutionizing the approach to diagnosing and treating mitochondrial diseases. We are overcoming traditional barriers in the field by bridging global patients and accelerating therapy development. At the heart of our pioneering platform are the patients, driving the integration of advanced technology into practical clinical solutions. #mitochondrial #POLG #rarediseases

As a volunteer, you will receive a free genomic analysis to understand your condition better. Your participation will benefit you and contribute to the development of new treatments. https://hubs.la/Q0398kP80 #mitochondrial #rarediseases #alphersdisease #children

We're spreading the joy with a 10% discount on all our products and services! It's the perfect time to explore our offerings and make the most of this special offer. https://hubs.la/Q038XRR_0 #discount #phdstudent #offers #research

The Mitochondrial Platform at Stemnovate Limited focuses on patient-centric research to accelerate clinical translation. Explore the fascinating world of genetics through innovative assays and cell models that offer new insights. #innovative #offernewinsights #research #Mitochondrial

February 28th is Rare Disease Day. Approximately 300 million people worldwide are affected by rare diseases, with about 80% of these conditions being genetic. Unfortunately, diagnosing these diseases often takes a long time, impacting families across generations. The Stemnovate Limited platform is on a mission to accelerate the diagnosis process and the development of new treatments. #RareDiseaseDay #diagnosis #newtreatments

Stemnovate Limited is excited to share that our innovative platform addressing rare diseases is now accepting new projects. Our focus is on advancing drug discovery for mitochondrial diseases in children, bringing together patients worldwide for this crucial initiative. Our goal is straightforward: to prioritize every life in scientific progress. https://hubs.la/Q038KFDG0 #rarediseases #mitochondrial #innovation #partnership

Stemnovate Limited - Our cell products and culture media are now available at Babraham Research Campus. As a special offer, we provide exclusive discounts on bulk orders and additional offers on specific products. Don't miss out! #discount #phdstudent #offers #research #scientist #research

At Stemnovate Limited, our Mitochondrial Platform prioritizes patient-centric research to fast-track clinical translation. Dive into the captivating realm of genetics with our cutting-edge assays and cell models, unveiling fresh perspectives. Uncover pioneering advancements in drug discovery and unravel the intricacies of bioinformatics for enhanced comprehension via data analysis. Contact us for engaging conversations on novel projects, research endeavors, and exciting discoveries. #Innovation #Research #Bioinformatics #mitochondrial #rarediseases #children

Reduce animal testing with the Stemnovate Limited Next-Gen Platform. What's unique? All tissue samples were ethically obtained and collected beyond routine veterinary procedures, ensuring no harm comes to animals. Our next-generation platform integrates sequencing for multi-species analysis and cellular reprogramming to create multicellular models, eliminating the need for animal testing when studying the effects on skin or brain cells. New drugs can be tested, and multi-parametric data can be provided to help you make better decisions—all without harming animals.

Stemnovate Limited Mitochondrial Platform is revolutionizing the approach to diagnosing and treating mitochondrial diseases. By bridging global patients and accelerating therapy development, we are overcoming traditional barriers in the field. At the heart of our pioneering platform are the patients, driving the integration of advanced technology into practical clinical solutions. #mitochondrial #POLG #rarediseases